HER2 Protein Expression and Gene Amplification in Androgen-Independent Prostate Cancer
Open Access
- 1 August 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (2) , 234-239
- https://doi.org/10.1309/vxkk-yvrh-9b11-ydpt
Abstract
The role of the HER2 receptor remains uncertain in the pathogenesis and progression of human prostate cancer. Previous studies have reported widely dKeywords
This publication has 18 references indexed in Scilit:
- Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working GroupJournal of Clinical Oncology, 1999
- A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinaseNature Medicine, 1999
- Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinomaCancer, 1997
- c-erbB-2 oncoprotein: A potential biomarker of advanced prostate cancerThe Prostate, 1997
- Overexpression of her-2/neu in human prostate cancer and benign hyperplasiaCancer Letters, 1996
- Immunohistochemical detection of oncogene proteins and neuroendocrine differentiation in different stages of prostate cancerPathology, 1995
- p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant ProstateJournal of Urology, 1992
- Expression of the p185 encoded by her2 oncogene in normal and transformed human tissuesInternational Journal of Cancer, 1990
- c-erbB-2 oncoprotein expression in primary human tumorsCancer, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989